A herd of bison grazes in the Lamar Valley of Yellowstone National Park on Aug. 3, 2016. (AP Photo/Matthew Brown, File)
Yellowstone National Park officials killed a newborn bison because its herd wouldn’t take the animal back after a man picked it up.
The calf became separated from its mother when the herd crossed the Lamar River in northeastern Yellowstone on Saturday. The unidentified man pushed the struggling calf up from the river and onto a roadway, park officials said in a statement Tuesday.
Park rangers tried repeatedly to reunite the calf with the herd but were unsuccessful. Visitors saw the calf walking up to and following cars and people, creating a hazard, so park staff killed the animal, according to the statement.
It's the latest example of Yellowstone visitors getting in trouble or hurt after approaching bison. Park officials euthanized a newborn bison after a similar incident in 2016, when a Canadian man and his son put the calf in their SUV, thinking they could rescue it.
The man pleaded guilty. He was fined $235 and ordered to pay $500 to the Yellowstone Park Foundation Wildlife Protection Fund.
Bison have gored several people in Yellowstone in recent years, often after they got too close to the animals.
Many of Yellowstone’s larger animals — including bison, which can run up to 35 mph (55 kilometers per hour) and weigh up to 2,000 pounds (900 kilograms) — are deceptively dangerous, even when they’re just grazing or resting.
Park rules require visitors to keep at least 25 yards (23 meters) away from wildlife including bison, elk and deer, and at least 100 yards (91 meters) away from bears and wolves.
Park officials are investigating the bison calf incident. The suspect was a white male in his 40s or 50s who was wearing a blue shirt and black pants, the statement said.
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
Dr. Vivek Cherin, Internal Medicine Physician at Amita Health, joined Cheddar's Search for a Cure to break down what we need to know about eligibility and availability of COVID-19 vaccine boosters.
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Carlo and Baker cover Facebook's big rebrand, the latest on Biden's economic agenda and more. Plus, ranking the best Halloween candy and the worst couple's costumes.
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
On this episode of 'Cheddar Innovates': President of iCAD breaks down how its technology is being used as a short-term breast cancer risk estimation for women; A look at Curiosity Stream's 'The Science of Thrills.'
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
